Altimmune Inc (ALT)
7.19
+0.12
(+1.70%)
USD |
NASDAQ |
May 02, 16:00
6.99
-0.20
(-2.78%)
After-Hours: 20:00
Altimmune Price to Book Value: 2.626 for May 2, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 01, 2024 | 2.582 |
| April 30, 2024 | 2.392 |
| April 29, 2024 | 2.336 |
| April 26, 2024 | 2.652 |
| April 25, 2024 | 2.630 |
| April 24, 2024 | 2.586 |
| April 23, 2024 | 2.765 |
| April 22, 2024 | 2.728 |
| April 19, 2024 | 2.524 |
| April 18, 2024 | 2.517 |
| April 17, 2024 | 2.571 |
| April 16, 2024 | 2.747 |
| April 15, 2024 | 2.758 |
| April 12, 2024 | 2.918 |
| April 11, 2024 | 3.068 |
| April 10, 2024 | 2.926 |
| April 09, 2024 | 3.068 |
| April 08, 2024 | 3.145 |
| April 05, 2024 | 3.320 |
| April 04, 2024 | 3.251 |
| April 03, 2024 | 3.393 |
| April 02, 2024 | 3.417 |
| April 01, 2024 | 3.736 |
| March 28, 2024 | 3.718 |
| March 27, 2024 | 3.247 |
| Date | Value |
|---|---|
| March 26, 2024 | 3.159 |
| March 25, 2024 | 3.116 |
| March 22, 2024 | 3.316 |
| March 21, 2024 | 3.317 |
| March 20, 2024 | 3.401 |
| March 19, 2024 | 3.182 |
| March 18, 2024 | 3.306 |
| March 15, 2024 | 3.590 |
| March 14, 2024 | 3.650 |
| March 13, 2024 | 3.973 |
| March 12, 2024 | 3.958 |
| March 11, 2024 | 3.594 |
| March 08, 2024 | 3.783 |
| March 07, 2024 | 3.652 |
| March 06, 2024 | 4.147 |
| March 05, 2024 | 4.093 |
| March 04, 2024 | 4.024 |
| March 01, 2024 | 4.402 |
| February 29, 2024 | 4.406 |
| February 28, 2024 | 4.836 |
| February 27, 2024 | 5.029 |
| February 26, 2024 | 4.122 |
| February 23, 2024 | 3.35 |
| February 22, 2024 | 3.230 |
| February 21, 2024 | 2.993 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.4752
Minimum
Nov 19 2019
13.39
Maximum
Jul 20 2020
2.220
Average
1.886
Median
Dec 31 2021
Price to Book Value Benchmarks
| Eli Lilly and Co | 56.08 |
| Amgen Inc | 23.95 |
| Pfizer Inc | 1.757 |
| Viking Therapeutics Inc | 8.944 |
| Precision BioSciences Inc | 3.898 |
Price to Book Value Related Metrics
| PS Ratio | 898.54 |
| Price | 7.19 |
| Earnings Yield | -23.23% |
| Market Cap | 509.74M |